US Stock MarketDetailed Quotes

KRTX Karuna Therapeutics

Watchlist
  • 329.830
  • 0.0000.00%
Close Mar 18 16:00 ET
12.60BMarket Cap-28118P/E (TTM)

About Karuna Therapeutics Company

Karuna Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies to address disabling neuropsychiatric conditions characterized by unmet medical needs. Its product candidate, KarXT is an oral modulator of muscarinic receptors that are located both in the central nervous system, or CNS, and various peripheral tissues.

Company Profile

SymbolKRTX
Company NameKaruna Therapeutics
Issue Price16.00
CEOMr. William Meury
MarketNASDAQ
Employees339
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Websitehttps://www.karunatx.com

Company Executives

  • Name
  • Position
  • Salary
  • William Meury
  • Director, President and Chief Executive Officer
  • --
  • Jonathan Rosin
  • Chief Human Resources Officer
  • --
  • Jason Brown
  • Senior Vice President, Finance, Principal Accounting Officer and Chief Financial Officer
  • --
  • Dr. Stephen Brannan, M.D.
  • Chief Medical Officer
  • 4.52M
  • Dr. Andrew Miller, PhD
  • Chief Operating Officer and President, Research and Development
  • 5.72M
  • William P. Kane, Jr
  • Chief Commercial Officer
  • --
  • Christopher J. Coughlin
  • Chairman of the Board
  • 626.09K
  • Dr. Jeffrey M. Jonas,M.D.
  • Director
  • 603.09K
  • Dr. Steven M. Paul, M.D.
  • Director
  • 13.14M
  • Laurie J. Olson
  • Independent Director
  • 615.34K
  • Dr. Atul Pande, M.D.
  • Independent Director
  • 618.09K
  • Denice M. Torres, J.D.,M.B.A.
  • Independent Director
  • 607.34K
  • Dr. James I. Healy, M.D.,PhD
  • Independent Director
  • 611.34K
  • Dr. David E. Wheadon, M.D.
  • Independent Director
  • 605.09K
  • Mia Kelley
  • General Counsel and Secretary
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg